It’s official – the Canadian government has approved the changes to Canada’s pharmaceutical patent regime. On May 16, 2017, Bill C-30 (the act intended to implement CETA into Canadian law) received royal assent, the final stage of the legislative process.
CETA tracker: CETA Bill C-30 receives royal assent to implement pharmaceutical patent reform
